Tufts Medical Center’s Post

Endometriosis is a disease of multiple organs, requiring as such multidisciplinary care. Treated mainly in specialist centres, a multidisciplinary team can consist of general surgeons with experience in colorectal surgery, urologist, thoracic surgeons as well as infertility specialists, endometriosis specialists, nurses, psychologists and so on. Various studies have looked at the importance of MDT in endometriosis. One of them conducted by an NHS UK team, highlights the benefits of MDT: - coordinated efforts between specialists with expertise in their disciplines in the management of a patient. - ensure higher quality decision-making, reduced incidence of questionable practices, standardised patient care and improved outcomes. - a full range of therapeutic options are considered early so patients receive appropriate and timely treatments. #ace #drdinos #endometriosisspecialist #endometriosiscare #endometriosisexcision

I am very excited to share my first paper in press at Journal of Cardiothoracic and Vascular Anesthesia, titled "Cardiopulmonary Bypass Blood Flow Rates and Major Adverse Kidney Events in Cardiac Surgery: A Propensity Score-Adjusted Before-After Study." Our study investigates the serious complication of cardiac surgery associated-acute kidney injury (CSA-AKI), which affects 5 to 30% of patients undergoing cardiac surgery and significantly increases morbidity and mortality. We aimed to explore the association between cardiopulmonary bypass blood flow rate (CPB-BFR) and major adverse kidney events at day 30 (MAKE30). We found that increased CPB-BFR was associated with a reduction in MAKE30, including mortality and the need for renal replacement therapy. Special thanks to my co-authors and everyone who supported this work. We hope our findings will contribute to the broader scientific community and inspire further research. Matteo Pozzi, Matthias Jacquet-lagreze, Marco Vola, MD, PhD, Maxime L., Thomas RODRIGUEZ Hospices Civils de Lyon - HCL, Hôpital cardiologique Louis Pradel #TeamHCL #Research #CardiacSurgery #CPB #Perfusionist

Multifocal ATs in 22 month young boy. Yesterday we have had a challenging ablation of multifocal ATs in a 22 month young boy with a history of cardiac surgery for correcting a pulmonary atresia and VSD with MAPCAs. Because a multitude of ATs and PACs competed effortlessly with SR it took us many hours to determine the location of the major 3 foci in the RA and the location of the SAN. (See the middle panel on the second slide for the incessant character of all the different atrial extras.) Subsequent RF applications at the various sites of earliest activation created a more and more normalized heart rhythm with each ablation. Final situation after 7.5 hours procedural time: Sinus rhythm with an atrial extra every once in a while. Ablations in extreme young and small patients is challenging for a lot of reasons. Size being absolutely one of them. That being said, we started off with smaller sized catheters but eventually ended up using HDgrid and TactiFlex DF instead. Abbott UMC Utrecht Performing physician: Dr. Peter Loh #epeeps #ep #arrhythmias #ablation #tachycardia #electrophysiology

Etiometry utilization led to an 18% reduction of time with vasoactive infusions…. These data (and more!) were shared at World Congress of Pediatric Cardiology and Cardiac Surgery, which took place in Washington, DC last month. Here, cardiac intensivist, Dr. Craig Futterman, presents the poster: "Use of a Risk Analytic Algorithm to Inform Weaning from Vasoactive Medication in Patients Following Pediatric Cardiac Surgery." Interested in more Etiometry outcomes data? Email Info@Etiometry.com for a list of our Clinical Highlights.   #VasoactiveMeds #ICU #PICU #PCICU #CriticalCare

📣 NICOR publishes 2024 Annual Report with new interactive reporting! 📊 NICOR has released its National Cardiac Audit Programme (NCAP) 2024 Annual Report, featuring 8 interactive sub-specialty clinical reports and a dedicated Annual Report for Patients, Carers, and the Public. Covering 1 April 2022 to 31 March 2023, this year’s report delves into post-pandemic shifts in cardiovascular service demand, delivery, and location-based variability. While activity levels for most cardiovascular sub-specialties have improved since 2020/21, some areas, such as adult and paediatric cardiac surgery, are still below pre-COVID levels. For the first time, NICOR's interactive reports offer detailed domain-level analyses and commentary, enabling stakeholders to explore performance by region and hospital. NICOR extends gratitude to all colleagues and stakeholders for their ongoing support and contributions. More info can be found here 👉 https://lnkd.in/eGDcn4df #NICOR #NCAP #AnnualReport2024

A research review co-authored by Himanshu Gupta, MD, Director of Cardiac Imaging at Valley Medical Group and Juan B. Grau, MD, FACS, FACC, Director of Cardiothoracic Surgery, The Valley Hospital, was recently published in the Canadian Journal of Cardiology. The authors explored two method of septal reduction therapy (SRT) for patients with hypertrophic cardiomyopathy (HCM) - alcohol septal ablation and septal myectomy - and highlight the need for further training of septal myectomy surgeons to ensure access to optimal septal reduction therapies for patients with HCM. SRT relieves left ventricular outflow tract obstruction and helps to reduce symptoms in patients with obstructive HCM. To read the full review, please visit https://lnkd.in/eMfW9eQZ. #CardiacPublication #CardiacResearch #MedicalResearch #MedicalPublication #ValleyHealthSystem

An increasing number of hospitals — including here at Stanford Health Care — are using intraoperative neuromonitoring (IONM) to monitor changes to the nervous system during surgery. IONM can allow surgeons to intervene in time in case a stroke or other neurologic injury occurs during an operation. But is reimbursing IONM worth it for health insurers? In collaboration with UPMC, Boston University School of Medicine, Yale University School of Medicine, and Duke University, we assessed the cost-benefit of utilizing IONM during cardiac surgery in the Journal of Stroke and Cerebrovascular Diseases. The answer: for high-risk patients, IONM may turn out to be cost-beneficial. Let me know your thoughts! https://lnkd.in/eWsxfuJS

AHA Scientific Sessions 2023: "Resource Utilization after Cardiac Surgery among ACHD: a Nationwide Analysis". Out of 91,565 ACHD admissions from 2012-2018, only 5% (n= 4,578) had at least one of the cardiac surgery procedures of interest coded as a procedure#1 or procedure#2. Most of the admissions had a valve surgery code as the primary procedure and #TOF or congenital anomalies of the pulmonary valve as the primary diagnosis. The median age of ACHD having a cardiac surgery intervention was 32 years (IQR 34 – 46), 46.6% were females and 61.7% had a private insurance. The median hospitalization cost was $54,400 (IQR 40,990 -74,520). High resource utilization (HRU) codes such as blood transfusions, pacemaker or diagnostic cath were used in 12.5%, 7.2% and 5.3% of the admissions. Overall, 19% of admissions had coded more than 1 HRU. Factors independently associated with hospitalization costs: - Sex: female ⬇️ 5.5% - LOS: 1 additional day ⬆️ 3% - Medium-sized hospitals ⬆️ 26.1% vs. Large - Respiratory failure ⬆️ 20.2% - Renal failure ⬆️ 14.9% - Blood transfusions ⬆️12.8% - Pacemaker ⬆️31.6% - Mortality during index admission 46.2%⬆️ As these patients become more prevalent and their treatment more complex, it's imperative to understand resource dynamics to enhance care delivery and reduce costs. Looking forward to more discussions on improving healthcare outcomes for the ACHD community! #AHA23 #ACHD #HealthcareOptimization #CardiacSurgery #Cardiology American Heart Association UPMC https://lnkd.in/egfsrDAw https://lnkd.in/ec2qYfyr

Rigid fixation is used to repair all fractures and osteotomies except sternotomies. As a leader in the musculoskeletal space, Zimmer Biomet recognized an opportunity to expand the benefits of rigid fixation to patients undergoing cardiac surgery. The SternaLock Blu Study was designed by a team of expert cardiothoracic surgeons and leading health economic researchers, and compared outcomes following sternal closure with SternaLock Blu or wire cerclage. A total of 236 patients undergoing elective cardiac surgery were enrolled at 12 hospitals in the United States. Patients were followed for six months to evaluate healing, clinical outcomes and costs. Patients treated with SternaLock Blu had improved sternal healing, fewer sternal complications and improved recovery. And, all of these clinical benefits were achieved at a cost savings. The method matters. SternaLock Blu proves it.